Prenatal exposure to chemicals in consumer and industrial items is linked to rising liver disease in children.
Researchers from Mount Sinai University have discovered a link between prenatal exposure to various endocrine-disrupting chemicals and the rising prevalence of a potentially cancer-causing liver disease in children.
It is the first comprehensive study of the relationship between prenatal exposure to certain chemicals and chemical mixtures and non-alcoholic fatty liver disease. The researchers used cytokeratin-18 as a novel marker for the condition in children. The findings, which were recently published in JAMA Network Open, highlight the significance of comprehending prenatal exposure to environmental chemicals as a risk factor for non-alcoholic fatty liver disease, a problem that is rapidly becoming more common among children and can result in severe chronic liver disease and liver cancer in adulthood.
“These findings can inform more efficient early-life prevention and intervention strategies to address the current non-alcoholic fatty liver disease epidemic,” said Vishal Midya, Ph.D., first author and postdoctoral researcher in the Department of Environmental Medicine and Public Health and a member of the Mount Sinai Institute for Exposomic Research at the Icahn School of Medicine at Mount Sinai.
Damaskini Valvi, MD, Ph.D., MPH, senior author, Assistant Professor of Environmental Medicine and Public Health, and a member of the Mount Sinai Institute for Exposomic Research at Icahn Mount Sinai, added, “We are all daily exposed to these chemicals through the food we eat, the water we drink, and the use of consumer products. This is a serious public health problem. These findings show that early life exposure to many endocrine-disrupting chemicals is a risk factor for pediatric non-alcoholic fatty liver disease, and draw attention to additional investigation needed to elucidate how environmental chemical exposures may interact with genetic and lifestyle factors in the pathogenesis of liver disease.”
Non-alcoholic fatty liver disease, one of the most widespread liver conditions in the world, is increasingly diagnosed in children, affecting 6 to 10 percent of the pediatric population and around 34 percent of obese children. Numerous pesticides, plastics, flame retardants, hazardous metals, and other environmental pollutants fall under the category of endocrine-disrupting chemicals.
Examples include perfluoroalkyl substances (PFAS), also known as “forever chemicals” used in nonstick cookware and food packaging, and polybrominated diphenyl ethers (PBDEs) used as flame retardants in furniture and infant products. Endocrine-disrupting chemicals interfere with hormone and metabolic systems in people. Several experimental studies have shown that exposures to these chemicals can lead to liver injury and non-alcoholic fatty liver disease; however, until now, the potential effects of prenatal mixture exposures to these chemicals have not been studied in humans.
In this study, researchers measured 45 chemicals in the blood or urine of 1,108 pregnant women from 2003 to 2010. The chemicals included endocrine-disrupting chemicals such as PFAS, organochlorine, and organophosphate pesticides, plasticizers (phenols, phthalates), PBDEs, and parabens. When the children reached the ages of 6 to 11 years old, scientists measured the levels of enzymes and cytokeratin-18 that indicate risk for liver disease in the children’s blood, finding elevated levels of those biomarkers in children who had been more highly exposed to environmental chemicals during pregnancy.
“By understanding the environmental factors that accelerate fatty liver disease, we can reduce people’s risk by giving them actionable information to make informed choices that reduce the risk or impact of the disease,” said Robert Wright, MD, MPH, Ethel H. Wise Chair of the Department of Environmental Medicine and Public Health and Co-Director of the Institute for Exposomic Research at Icahn Mount Sinai.
“Exposomics is the wave of the future because once you’ve sequenced the human genome, which has been done, there isn’t much more you can do in genomics alone. The missing piece of the puzzle for us to understand different diseases is to measure their environmental causes, and exposomics is a way to accelerate our knowledge of how the environment is affecting our health.”
Reference: “Association of Prenatal Exposure to Endocrine-Disrupting Chemicals With Liver Injury in Children” by Vishal Midya, Ph.D., MStat, Elena Colicino, Ph.D., David V. Conti, Ph.D., Kiros Berhane, Ph.D., Erika Garcia, Ph.D., Nikos Stratakis, Ph.D., Sandra Andrusaityte, Ph.D., Xavier Basagaña, Ph.D., Maribel Casas, Ph.D., Serena Fossati, MD, Ph.D., Regina Gražulevičienė, MD, Line Småstuen Haug, Ph.D., Barbara Heude, Ph.D., Léa Maitre, Ph.D., Rosemary McEachan, Ph.D., Eleni Papadopoulou, Ph.D., Theano Roumeliotaki, MPH, Claire Philippat, Ph.D., Cathrine Thomsen, Ph.D., Jose Urquiza, Ph.D., Marina Vafeiadi, Ph.D., Nerea Varo, Ph.D., Miriam B. Vos, MD, John Wright, MD, Rob McConnell, MD, Ph.D., Martine Vrijheid, Ph.D., Lida Chatzi, MD, PhD and Damaskini Valvi, MD, MPH, Ph.D., 6 July 2022, JAMA Network Open.
The study participants were enrolled in the Human Early-Life Exposome project, a collaborative network of six ongoing population-based prospective birth cohort studies from six European countries—France, Greece, Lithuania, Norway, Spain, and Britain. Limitations of this study include the inability to conduct a liver biopsy, considered the gold standard to establish a causal link with non-alcoholic fatty liver disease, because of the risk and ethical limitations due to the children’s age.
This research was funded by the National Institute of Environmental Health Science (NIEHS) and the European Community’s Seventh Framework Programme.